Nieuwsbrieven
2024: Nieuwsbrief 2024-04 | Nieuwsbrief 2024-03 | Nieuwsbrief 2024-02 | Nieuwsbrief 2024-01
2023: Nieuwsbrief 2023-04 | Nieuwsbrief 2023-03 | Nieuwsbrief 2023-02 | Nieuwsbrief 2023-01
2022: Nieuwsbrief 2022-04 | Nieuwsbrief 2022-03 | Nieuwsbrief 2022-02 | Nieuwsbrief 2022-01
2021: Nieuwsbrief 2021-01
2020: Nieuwsbrief 2020-01
2019: Nieuwsbrief 2019-02 | Nieuwsbrief 2019-01
2018: Nieuwsbrief 2018-03 | Nieuwsbrief 2018-02 | Nieuwsbrief 2018-01
Nieuws
IN CONVERSATION WITH PROFESSOR RODNEY HICKS
Datum: 08 | 10 | 19
Professor Rodney Hicks visited the LUMC following an invitation of the department of Radiology and on September 30, 2019 he gave the keynote lecture "Precision Medicine - choosing the right treatment at the right time by doing the right test". The same day Professor Hicks participated in a special session of the regional nuclear radiology rounds with a presentation about “Imaging of melanoma, including immunotherapy monitoring”.
Rodney Hicks is a Professorial Fellow of the University of Melbourne and Director of the Centre for Molecular Imaging and Therapeutic Nuclear Medicine at the Peter MacCallum Cancer Centre in Melbourne, Australia. In 2001this centre installed the first PET/CT outside of Europe and North America. The PET facility, founded by him in 1996, now has 4 PET/CT devices and performs over 9,000 scans per year. He has pioneered the use of PET and PET/CT in the assessment of cancer and has introduced a number of novel PET tracers. He is actively involved in therapeutic nuclear medicine, especially for the treatment of neuroendocrine tumours having first established peptide receptor radionuclide therapy (PRRT) in Australia in 1996. The Neuroendocrine Service, of which he is Co-Chair, was recently certified as a European Neuroendocrine Tumour Society Centre of Excellence, the first to be granted beyond Europe. His group has been active in the clinical development of prostate cancer theranostics. He has published 500 peer-reviewed articles and more than 20 book chapters. He holds numerous national and international research grants and is Editor-in-Chief of Cancer Imaging and International Associate Editor of The Journal of Nuclear Medicine as well as serving on 6 other editorial boards including Endocrine-Related Cancer.
In this internet edition of the Tijdschrift voor Nucleaire Geneeskunde (TvNG) Professor Hicks discusses in a video interview the relevance of recent advances in theranostics and new technologies for nuclear medicine in conversation with Professor Lioe-Fee de Geus-Oei, past editor-in-chief of the TvNG